体内CAR-Tin vivo CAR-T
体内重编程T细胞
每条都摘自下方编号的来源原文;只写事实,不写预测或建议。
技术简介
- Starna正在开发直接在患者体内重编程细胞的RNA药物。1
Starna is developing RNA medicines that are designed to reprogram cells inside the body — or “in vivo” — while also branching into fields beyond oncology.
体内重编程T细胞
每条都摘自下方编号的来源原文;只写事实,不写预测或建议。
Starna is developing RNA medicines that are designed to reprogram cells inside the body — or “in vivo” — while also branching into fields beyond oncology.